The Advocacy Training Session

 

The first training for certification will include a
variety of topics to give advocates a well-grounded understanding of
methadone treatment, research, regulations and laws that protect
methadone patients and programs.

 

  1. Addiction
    and Methadone
    Tom Payte, MD (Drug Dependence
    Associates) and Joycelyn Woods, MA. (NAMA) The
    biological constructs of addiction will be explained in a way that
    can be understood by lay people (i.e. opiate receptors, Endorphins)
    Methadone dose and what is considered an adequate dose and why it is
    important and what methadone does to make you feel normal.
  2. Regulations
    and Accreditatio
    n
    C. Todd
    Rosendale (CSAT/DPT), Sharon Dow (Joint Commission), Bettye Harrison
    (CARF) and Joanne Page (COA).The new federal regulations will be explained:  What
    they are and how they relate to the state regulations? Accreditation
    and what an accreditation survey is, how it is done, and how
    advocates can be involved.
  3. The
    Different Faces of Advocacy

    Presenters to be announced.
    Advocates from around the country will explain what they do to
    advance the goals of methadone advocacy. This session will also
    explain the different types of advocacy that advocates are involved
    in.
  4. How
    to End Methadone Stigma
    Herman Joseph, Ph.D. The history of
    methadone stigma will be presented and how it has impacted methadone
    treatment and the recipients of it. A plan for advocates to work on
    for ending it will be revealed.
  5. Advocate
    Certification

    Walter Ginter (NAMA Training and Certification Director) What is certification and how it
    will professionalize those committed to methadone advocacy.  The Advocates Code of Ethics, the Goals of Methadone
    Advocacy, and Advocate Certification.

         Top

Similar Posts

  • Basic Pharmacology: How Methadone Works? Part III Drugs and Conditions That Impact On the Action of Methadone by Joycelyn Woods

    Admin 09/16/2021

    Education Series Number 5.3 February 2001 (Revised) Joycelyn Woods has a graduate degree in neuroscience and psychopharmacology. She has published in neuroscience journals and is recognized internationally for her methadone advocacy work. She is a recipient of the “Richard Lane Methadone Advocacy Award.” Methadone Metabolism Methadone was once considered to be pretty much the same…

  • LAAM Warning

    Admin 07/05/2021

    FDA Warns About Orlaam T01-15 Print Media: 301-827-6242 April 20, 2001 Broadcast Media: 301-827-3434   Consumer Inquiries: 888-INFO-FDA The U.S. Food and Drug Administration (FDA) issued a new warning about health risks associated with levomethadyl acetate HC, a.k.a. Orlaam, a drug used to treat opiate addiction. FDA Announces Labeling Changes Following Cardiac Adverse Events With…

  • Letter to Senator McCain

    Admin 02/05/2023

    March 3, 1999   Dear Senator McCain: Your introduction of Senate Bill 423 is disheartening. That someone with such an esteemed position as senator would base public policy on the hearsay of a proselytizer instead of sound and extensive scientific evaluations is wrong. It is unfortunate that our government once primarily composed of statesmen today…

  • NAMA

    Admin 04/23/2021

    Telling The Untold Methadone Success Stories This Treatment Works “There may be no more effective way to contain heroin abuse than methadone, a drug that blocks an addict’s craving. Yet new efforts to expand use of methadone have inspired new attacks on it, attacks that deny common sense.“ -The New York Times, April 8, 1990…

  • NAMA Policy Statements & Research

    Admin 12/11/2022

    These documents communicate the aspects of what quality methadone maintenance treatment should be. This is not a complete list of the Policy Statements that NAMA has issued.  Some important research by addiction treatment experts has been added. Methadone Medical Maintenance Policy Statement 1 April 1994 The Policy of Blind Dosing and Patient Dignity Policy Statement…

  • About Webring

    Admin 06/30/2021

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager: Greg Keller,…